news in brief

STA to open catalyst screening centre in Changzhou in November

By Gareth Macdonald

- Last updated on GMT

STA facility in Changzhou, China (source company website)
STA facility in Changzhou, China (source company website)

Related tags Hydrogen Nitrogen

STA Pharmaceutical Co is setting up a metal catalyst-screening center at its facility in Changzhou, China.

The firm – a subsidiary of WuXi AppTec – said the centre would support screening activities for metal catalysts, ligands, bases, acids, chemical resolving reagents and amide formation coupling reagents.

STA said the center would open next month adding that staff in training at its facility in Shanghai will relocate to Changzhou when the facility is up and running.

News of the new center comes just months​ after WuXi merged STA’s active pharmaceutical ingredient (API) business with its development services operation.

Earlier this year​ STA told us it would employ a staff of 300 people at the Changzhou site, including 230 process chemists and 70 analytical chemists.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Related suppliers

Follow us

Webinars